Traeger COOK 深 沪
等待开盘 09-17 09:30:00 美东时间
48.69
+0.590
+1.23%
华盛通- 最 高49.315
- 今 开48.09
- 成交量 1.68万股
- 最 低 48.01
- 昨 收 48.10
- 总市值 1.36亿
- 52周最高 86.59
- 市盈率 静 --
- 换手率 0.60%
- 52周最低 20.91
- 委 比 21.21%
- 总股本 279.82万
- 历史最高 1629.55
- 量 比 0.73
- 振 幅 2.71%
- 历史最低 24.15
- 每 手 1
- 风险率 12.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Asure Celebrates 50 Small and Mid-Sized Business Honorees at 2026 Asure50 Awards
Asure Software announced its second annual Asure50 Awards, honoring 50 North American small and mid-sized businesses across 13 industries, 20 U.S. states, and one Canadian province. The ceremony will take place on September 3, 2026, in Austin, Texas. This year’s honorees, averaging 41 employees, include companies from healthcare, manufacturing, and hospitality sectors. California leads with 11 honorees. The event will feature a keynote on employe...
08-27 20:01
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
Canaccord Genuity Maintains Buy on Traeger, Raises Price Target to $77
Canaccord Genuity analyst Brian McNamara maintains Traeger (NYSE:COOK) with a Buy and raises the price target from $75 to $77.
08-07 06:41
Traeger Lowers FY2026 Sales Guidance from $465.000M-$485.000M to $435.000M-$465.000M vs $471.371M Est
Traeger (NYSE:COOK) lowers FY2026 sales outlook from $465.000 million-$485.000 million to $435.000 million-$465.000 million vs $471.371 million estimate.
08-06 04:33
These consumer discretionary stocks stand out for both value and performance
As investors continue to search for stocks that can deliver strong returns without trading at stretched valuations, several names in the consumer discretionary sector are standing out. Currently, 11 c...
06-11 23:56
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
B. Riley Securities Maintains Neutral on Traeger, Raises Price Target to $40
B. Riley Securities analyst Anna Glaessgen maintains Traeger (NYSE:COOK) with a Neutral and raises the price target from $30 to $40.
05-12 23:48
